Clinical Trial Update: An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy of 100 mg daily Saredutant in elderly patients with major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Saredutant (saredutant)

Snippet

Sponsor: Sanofi | Conditions: Depressive Disorder | Phase 3 | Status: COMPLETED